Analysis Metabolite Name Measured Value Units Sample description Tissue
Reversed phase POSITIVE ION MODESerotonin0.023uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.03uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.036uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.038uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.039uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.041uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.042uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.043uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.044uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.044uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.045uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.046uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.046uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.046uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.048uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.05uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.052uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.053uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.053uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.054uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.055uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.055uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.056uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.057uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.057uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.059uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.06uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.06uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.061uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.063uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.063uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.065uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.065uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.067uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.068uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.068uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.069uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.07uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.07uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.071uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.072uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.073uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.074uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.076uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.076uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.076uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.078uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.08uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.08uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.081uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.082uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.083uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.083uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.083uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.085uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.085uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.086uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.087uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.088uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.088uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.088uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.089uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.089uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.09uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.09uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.091uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.091uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.093uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.094uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.094uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.095uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.095uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.095uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.096uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.098uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.098uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.101uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.102uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.106uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.107uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.108uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.109uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.11uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.11uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.11uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.11uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.112uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.113uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.113uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.114uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.114uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.114uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.117uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.117uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.119uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.122uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.122uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.126uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.128uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.131uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.131uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.131uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.132uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.132uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.132uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.133uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.135uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.136uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.137uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.138uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.139uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.143uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.143uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.156uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.159uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.16uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.161uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.161uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.165uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.178uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.183uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.185uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.188uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.189uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.191uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.191uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.198uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.2uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.201uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.201uMWM47 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.204uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.206uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.21uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.214uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.218uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.219uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.219uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.221uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin0.239uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.242uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.244uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.247uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.263uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.265uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.265uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.266uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.271uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.275uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.276uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.276uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.277uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.297uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.298uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.298uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.299uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.301uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.301uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.313uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.332uMA375 LCT tumor
Reversed phase POSITIVE ION MODESerotonin0.333uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.345uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.362uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.388uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.392uMA375 CTRL tumor
Reversed phase POSITIVE ION MODESerotonin0.397uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.418uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.421uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.459uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.479uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.492uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.498uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.51uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.512uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.539uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.572uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.575uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.617uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.663uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.676uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.758uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.776uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.785uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.803uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.837uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin0.908uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.914uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin0.924uMWM47 LCT plasma
Reversed phase POSITIVE ION MODESerotonin0.971uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin1.04uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin1.103uMA375 LCT plasma
Reversed phase POSITIVE ION MODESerotonin1.117uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODESerotonin1.155uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin1.166uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESerotonin1.189uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESerotonin1.2uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODESerotonin1.2uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin1.286uMA375 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin1.32uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODESerotonin1.402uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODESerotonin1.604uMWM3311 LCT-MCT plasma

Return to search page
  logo